Status:
COMPLETED
Prognostic Performance of the Naples Prognostic Score
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Nutritional and Metabolic Diseases
Oncologic Disorders
Eligibility:
All Genders
Brief Summary
To investigate the prognostic performance of the Naples Prognostic Score in gastric cancer patients undergoing surgery
Detailed Description
The outcome of oncological patients is related not only to the tumor status but also to the host. Particularly the patient's immune and nutritional status have been recently associated with short- and...
Eligibility Criteria
Inclusion
- all patients undergoing surgery at our institution for proven gastric adenocarcinoma will be enrolled in the present study
Exclusion
- Patients with lower esophageal adenocarcinoma or cancer crossing the esophagogastric junction with its epicenter in the proximal 2 cm of stomach, which were taken apart from stomach cancers in the last two AJCC cancer staging editions, will be excluded.
- Patients with ongoing infections, concomitant immune-mediated diseases, or on drugs capable of affecting neutrophil and/or lymphocyte counts (e.g., steroids, immunosuppressants, etc.) will be excluded from the study.
Key Trial Info
Start Date :
January 1 2000
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 30 2017
Estimated Enrollment :
477 Patients enrolled
Trial Details
Trial ID
NCT03272646
Start Date
January 1 2000
End Date
June 30 2017
Last Update
September 5 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.